-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Coronavirus disease 19 ( COVID-19 ), a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has sparked a global pandemic
.
Acute sequelae of COVID-19 (PASC) is provisionally defined as symptoms that persist or worsen for more than 4 weeks, or the onset of new symptoms attributable to COVID-19, affecting 20-60% of patients
.
COVID-19
Common complaints are fatigue, dyspnea, brain fog, and orthostatic intolerance, as well as various systemic complaints
.
PASC is a multisystem disease, however, the exact pathophysiology remains poorly understood
.
infection immune vascular thrombosis
Symptoms of intravenous immunoglobulin reactivity in PASC patients suggest cerebral hypoperfusion, small fiber neuropathy (SFN), and autonomic dysregulation due to cerebrovascular arterial dysfunction
.
Postural orthostatic tachycardia syndrome (POTS) is characterized by symptoms similar to PASC, including chronic fatigue, orthostatic intolerance, and brain fog associated with decreased orthostatic cerebral blood flow and dysautonomia
.
Therefore, in addition to healthy controls, POTS patients provide a useful comparison group to be able to identify pathophysiologies that differ from PASC
.
From this, Peter Novak et al.
of Harvard Medical School hypothesized that PASCs are associated with autoimmune/inflammation-mediated widespread cerebrovascular and metabolic dysregulation and neuropathies
.
They retrospectively evaluated consecutive patients with chronic fatigue, brain fog, and normal intolerance consistent with PASC
.
The control group consisted of patients with postural orthostatic tachycardia syndrome (POTS) and healthy participants
.
They found: Nine patients with PASC were evaluated 0.
8±0.
3 years after mild COVID-19 infection and observed as home
.
Autonomic, pain, brain fog, fatigue, and dyspnea were all abnormal in PASC and POTS (n = 10) compared to controls (n = 15)
.
Normal CBFv decreased in PASC (-20.
0 ± 13.
4%) and POTS (-20.
3 ± 15.
1%) compared with controls (-3.
0 ± 7.
5%, p = 0.
001), independent of end-tidal carbon dioxide in PASC, but Caused by hypoventilation in POTS
.
Anteroposterior CBFv was decreased in PASC, including subjects without (n = 6) and with (n = 3) anteroposterior tachycardia
.
.
Autonomic abnormalities were common (100% in both PASC and POTS) but were milder in PASC (P = 0.
002)
The PASC and POTS cohorts differed in frequency of small fiber neuropathy (89% vs 60%), but not in inflammatory markers (67% vs 70%)
.
Supine and orthostatic hypocapnia were observed in PASC
.
The significance of this study lies in the discovery that PASC following mild COVID-19 infection is associated with multisystem involvement , including: (1) cerebrovascular dysregulation and persistent cerebral arterial vasoconstriction; (2) small fiber neuropathy and related Autonomic nervous system disorders; (3) respiratory system disorders; and (4) chronic inflammation
.
Original source:
Novak P, Mukerji SS, Alabsi HS, et al.
Multisystem Involvement in Post‐Acute Sequelae of Coronavirus Disease 19.
Annals of Neurology .
Published online January 18, 2022:ana.
26286.
Multisystem Involvement in Post‐Acute Sequelae of Coronavirus Disease 19.
Annals of Neurology